Oligodendroglioma other diagnostic studies: Difference between revisions

Jump to navigation Jump to search
No edit summary
 
(3 intermediate revisions by one other user not shown)
Line 4: Line 4:


==Overview==
==Overview==
Other diagnostic studies for oligodendroglioma include [[biopsy]] (homogeneous, compact, rounded cells with distinct borders and clear cytoplasm surrounding a dense central nucleus and perinuclear halo) and [[fish|fluorescent in-situ hybridization (FISH) technique]] (deletions of [[chromosome 1|chromosome 1p]] and [[chromosome 19|19q]]).
Other [[Diagnostic study of choice|diagnostic studies]] for [[oligodendroglioma]] include [[biopsy]] ([[homogeneous]], [[Compact tissue|compact]], rounded [[Cells (biology)|cells]] with [[Distinctive feature|distinct]] [[Borderline|borders]] and clear [[cytoplasm]] surrounding a [[dense]] [[central]] [[nucleus]] and [[Perinuclear space|perinuclear]] [[Halo (medicine)|halo]]) and [[Fish|fluorescent in-situ hybridization (FISH) technique]] ([[Deletion (genetics)|deletions]] of [[Chromosome 1|chromosome 1p]] and [[Chromosome 19|19q]]).


==Other Diagnostic Studies==
==Other Diagnostic Studies==
===Biopsy===
===Biopsy===
*Biopsy may be performed to help confirm the diagnosis of oligodendroglioma
*[[Biopsy]] may be [[Performance status|performed]] to help [[Confirmatory factor analysis|confirm]] the [[diagnosis]] of [[oligodendroglioma]].
*On [[biopsy]], oligodendroglioma is characterized by homogeneous, compact, rounded cells with distinct borders and clear cytoplasm surrounding a dense central nucleus and perinuclear halo, giving it the characteristic “''fried egg''” appearance<ref name="pmid25943885">{{cite journal| author=Wesseling P, van den Bent M, Perry A| title=Oligodendroglioma: pathology, molecular mechanisms and markers. | journal=Acta Neuropathol | year= 2015 | volume= 129 | issue= 6 | pages= 809-27 | pmid=25943885 | doi=10.1007/s00401-015-1424-1 | pmc=PMC4436696 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=25943885  }} </ref>
*On [[biopsy]], [[oligodendroglioma]] is characterized by [[homogeneous]], [[Compact tissue|compact]], rounded [[Cell (biology)|cells]] with [[Distinctive feature|distinct]] borders and clear [[cytoplasm]] surrounding a [[dense]] [[central]] [[nucleus]] and [[Perinuclear space|perinuclear]] [[Halo (medicine)|halo]], giving it the characteristic “''fried [[Egg (biology)|egg]]''” [[appearance|appearance.]]<ref name="pmid25943885">{{cite journal| author=Wesseling P, van den Bent M, Perry A| title=Oligodendroglioma: pathology, molecular mechanisms and markers. | journal=Acta Neuropathol | year= 2015 | volume= 129 | issue= 6 | pages= 809-27 | pmid=25943885 | doi=10.1007/s00401-015-1424-1 | pmc=PMC4436696 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=25943885  }} </ref>
*Biopsy may be done at the time of [[surgical resection]] of oligodendroglioma
*[[Biopsy]] may be done at the [[Time series|time]] of [[surgical resection]] of [[oligodendroglioma]].
*Biopsy may be of two types:
*[[Biopsy]] may be of two types:
**Open biopsy
**Open [[biopsy]]
**[[stereotactic|Stereotactic biopsy]]  
**[[stereotactic|Stereotactic biopsy]]  
*Indications for open biopsy and [[stereotactic|stereotactic biopsy]] are described below:<ref name="pmid15509821">{{cite journal| author=Eskandar EN, Loeffler JS, O'Neill AM, Hunter GJ, Louis DN| title=Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 33-2004. A 34-year-old man with a seizure and a frontal-lobe brain lesion. | journal=N Engl J Med | year= 2004 | volume= 351 | issue= 18 | pages= 1875-82 | pmid=15509821 | doi=10.1056/NEJMcpc049025 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15509821  }} </ref>
*[[Indications and usage|Indications]] for open [[biopsy]] and [[stereotactic|stereotactic biopsy]] are described below:<ref name="pmid15509821">{{cite journal| author=Eskandar EN, Loeffler JS, O'Neill AM, Hunter GJ, Louis DN| title=Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 33-2004. A 34-year-old man with a seizure and a frontal-lobe brain lesion. | journal=N Engl J Med | year= 2004 | volume= 351 | issue= 18 | pages= 1875-82 | pmid=15509821 | doi=10.1056/NEJMcpc049025 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15509821  }} </ref>


{| style="border: 0px; font-size: 90%; margin: 3px; width: 600px" align="center"
{| style="border: 0px; font-size: 90%; margin: 3px; width: 600px" align="center"
| valign="top" |
 
|+
|+
'''Indications for different types of biopsies'''
! style="background: #4479BA; width: 200px;" | {{fontcolor|#FFF|Type of biopsy}}
! style="background: #4479BA; width: 200px;" | {{fontcolor|#FFF|Type of biopsy}}
! style="background: #4479BA; width: 400px;" | {{fontcolor|#FFF|Indications}}
! style="background: #4479BA; width: 400px;" | {{fontcolor|#FFF|Indications}}
Line 25: Line 26:
[[craniotomy|Open biopsy]]
[[craniotomy|Open biopsy]]
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
*Surgically resectable masses
*[[Surgery|Surgically]] [[Resection|resectable]] [[Mass|masses]]
*Lesions in accessible and relatively “silent” areas of the brain or in areas of the brain with a mild postoperative neurologic deficit
*[[Lesions]] in [[Accessible image|accessible]] and [[Relatively compact|relatively]] “[[Silent News|silent]]” [[Area|areas]] of the [[brain]] or in [[Area|areas]] of the [[brain]] with a mild [[Post operative complications|postoperative]] [[Neurological|neurologic]] deficit
*Appearance consistent with [[tumor]] on the [[MRI]]
*[[Appearance]] consistent with [[tumor]] on the [[MRI]]
*Large [[tumors]] exerting mass effect
*Large [[tumors]] exerting [[mass effect]]
|-
|-
| style="padding: 5px 5px; background: #DCDCDC;font-weight: bold" |
| style="padding: 5px 5px; background: #DCDCDC;font-weight: bold" |
[[Stereotactic|Stereotactic biopsy]]
[[Stereotactic|Stereotactic biopsy]]
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
*Deep-seated [[tumor]] that is not amenable to resection
*Deep-seated [[tumor]] that is not amenable to [[resection]]
*Lesions in which the radiological and clinical findings are ambiguous
*[[Lesions]] in which the [[radiological]] and [[clinical]] findings are ambiguous
*Diffuse or multiple lesions
*[[Diffuse]] or multiple [[lesions]]
*Appearance that suggests a [[lymphoma]], which would not require resection
*[[Appearance]] that [[Suggestion|suggests]] a [[lymphoma]], which would not require [[resection]]
*Change in the appearance of a previously diagnosed or treated [[tumor]]
*[[Change detection|Change]] in the [[appearance]] of a previously [[Diagnose|diagnosed]] or [[Treatments|treated]] [[tumor]]
*Assessment of tumor after treatment (to distinguish between [[radiation|radiation necrosis]] and tumor recurrence)
*[[Assessment and Plan|Assessment]] of [[tumor]] after [[Treatments|treatment]] (to distinguish between [[radiation|radiation necrosis]] and [[tumor]] [[Recurrence plot|recurrence]])
|}
|}


===Fluorescent in-situ hybridization (FISH) technique===  
===Fluorescent in-situ hybridization (FISH) technique===  
*[[FISH]] demonstrates deletions of [[chromosome 1|chromosome 1p]] and [[chromosome 19|19q]]<ref name="turk">{{Citation |last=Ersen |first=Ayca|year=2008 |title=Pathology of malignant gliomas: Challenges of everyday practice and the WHO 2007 |publisher=Turkish Journal of Pathology |publication-place= |page= |url=http://www.turkjpath.org/text.php3?id=645 |accessdate=9 October, 2015 }}</ref>
*[[FISH]] demonstrates [[Deletion (genetics)|deletions]] of [[chromosome 1|chromosome 1p]] and [[chromosome 19|19q.]]<ref name="turk">{{Citation |last=Ersen |first=Ayca|year=2008 |title=Pathology of malignant gliomas: Challenges of everyday practice and the WHO 2007 |publisher=Turkish Journal of Pathology |publication-place= |page= |url=http://www.turkjpath.org/text.php3?id=645 |accessdate=9 October, 2015 }}</ref>


==References==
==References==

Latest revision as of 21:03, 4 June 2019

Oligodendroglioma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Oligodendroglioma from other Diseases

Epidemiology & Demographics

Risk Factors

Screening

Natural History, Complications, and Prognosis

Diagnosis

Staging

History & Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Oligodendroglioma other diagnostic studies On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Oligodendroglioma other diagnostic studies

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Oligodendroglioma other diagnostic studies

CDC on Oligodendroglioma other diagnostic studies

Oligodendroglioma other diagnostic studies in the news

Blogs on Oligodendroglioma other diagnostic studies

Directions to Hospitals Treating Oligodendroglioma

Risk calculators and risk factors for Oligodendroglioma other diagnostic studies

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Sara Mohsin, M.D.[2]Sujit Routray, M.D. [3]

Overview

Other diagnostic studies for oligodendroglioma include biopsy (homogeneous, compact, rounded cells with distinct borders and clear cytoplasm surrounding a dense central nucleus and perinuclear halo) and fluorescent in-situ hybridization (FISH) technique (deletions of chromosome 1p and 19q).

Other Diagnostic Studies

Biopsy

Indications for different types of biopsies
Type of biopsy Indications

Open biopsy

Stereotactic biopsy

Fluorescent in-situ hybridization (FISH) technique

References

  1. Wesseling P, van den Bent M, Perry A (2015). "Oligodendroglioma: pathology, molecular mechanisms and markers". Acta Neuropathol. 129 (6): 809–27. doi:10.1007/s00401-015-1424-1. PMC 4436696. PMID 25943885.
  2. Eskandar EN, Loeffler JS, O'Neill AM, Hunter GJ, Louis DN (2004). "Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 33-2004. A 34-year-old man with a seizure and a frontal-lobe brain lesion". N Engl J Med. 351 (18): 1875–82. doi:10.1056/NEJMcpc049025. PMID 15509821.
  3. Ersen, Ayca (2008), Pathology of malignant gliomas: Challenges of everyday practice and the WHO 2007, Turkish Journal of Pathology, retrieved 9 October, 2015 Check date values in: |accessdate= (help)


Template:WikiDoc Sources